| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $499.3M | -2.3% |
| Cost of Revenue | $103.0M | +12.1% |
| Gross Profit | $396.3M | -5.4% |
| R&D Expense | $127.4M | +8.8% |
| SG&A Expense | $111.4M | +16.7% |
| Operating Income | -$1.28B | -62.6% |
| Pre-tax Income | -$1.32B | -63.0% |
| Income Tax | $147.3M | +153.4% |
| Net Income | -$1.47B |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $43.8M | -30.8% |
| Short-term Investments | $0 | — |
| Accounts Receivable | $189.3M | +0.0% |
| Current Assets | $264.6M | -1.3% |
| Total Assets | $2.41B | -32.2% |
| Current Liabilities | $317.4M | +1.7% |
| Long-term Debt | $2.38B | +10.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.2M | -96.6% |
| Capital Expenditures | $2.5M | -8.1% |
| Investing Cash Flow | -$278.6M | +89.4% |
| Financing Cash Flow | $265.2M | -89.6% |
| Free Cash Flow | $725K | -99.2% |
| -174.5% |
| EPS (Basic) | -$129.83 | -142.9% |
| EPS (Diluted) | -$129.83 | -142.9% |
| Total Liabilities |
| $2.79B |
| +8.3% |
| Stockholders' Equity | -$383.1M | -139.1% |